{"DataElement":{"publicId":"3915160","version":"1","preferredName":"Nasopharyngeal Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the nasopharyngeal cancer based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2452521v1.0:3914894v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2452521","version":"1","preferredName":"Nasopharynx Tumor Pathologic N Stage","preferredDefinition":"information related to pathologic N stage of the nasal part of the pharynx, lying above the level of the soft palate.","longName":"NASOPHAR_TUMOR_P_N_S","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452490","version":"1","preferredName":"Nasopharynx Neoplasm","preferredDefinition":"The nasal part of the pharynx, lying above the level of the soft palate.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12423:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharynx","conceptCode":"C12423","definition":"The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-66FC-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7DF0-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":"2013-01-01","createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"TAYLORT","dateModified":"2020-01-08","changeDescription":"1/8/20 tmt added Registration Status.; 1/8/20 Received permission from Brian Campbell to transfer ownership from CTEP to NCI Standards. Changed workflow from retired to draft new with permission from CTEP to reuse with AJCC TMN stage CDEs. mc 10/3/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3914894","version":"1","preferredName":"Nasopharyngeal Cancer American Joint Committee on Cancer (AJCC) Edition 7 N Stage","preferredDefinition":"A finding about one or more characteristics of nasopharyngeal cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3914894v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3b","valueDescription":"Nasopharyngeal Cancer pN3b TNM Finding v7","ValueMeaning":{"publicId":"3914896","version":"1","preferredName":"Nasopharyngeal Cancer pN3b TNM Finding v7","longName":"3914896","preferredDefinition":"Nasopharyngeal cancer with extension to the supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho.  It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder.  This would include caudal portions of levels IV and VB.  All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN3b TNM Finding v7","conceptCode":"C88975","definition":"Nasopharyngeal cancer with extension to the supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho.  It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder.  This would include caudal portions of levels IV and VB.  All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0AE2-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0AFE-9A6E-E040-BB89AD43310E","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"N3a","valueDescription":"Nasopharyngeal Cancer pN3a TNM Finding","ValueMeaning":{"publicId":"3914898","version":"1","preferredName":"Nasopharyngeal Cancer pN3a TNM Finding","longName":"3914898","preferredDefinition":"Nasopharyngeal cancer with metastasis to one or more lymph nodes greater than 6 cm in greatest dimension. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN3a TNM Finding v6 and v7","conceptCode":"C64478","definition":"Nasopharyngeal cancer with metastasis to one or more lymph nodes greater than 6 cm in greatest dimension. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0B0B-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0B27-9A6E-E040-BB89AD43310E","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"N0","valueDescription":"Nasopharyngeal Cancer pN0 TNM Finding","ValueMeaning":{"publicId":"3914900","version":"1","preferredName":"Nasopharyngeal Cancer pN0 TNM Finding","longName":"3914900","preferredDefinition":"Nasopharyngeal cancer with no metastasis to regional lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN0 TNM Finding v6 and v7","conceptCode":"C64474","definition":"Nasopharyngeal cancer with no metastasis to regional lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0B34-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0B50-9A6E-E040-BB89AD43310E","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"N1","valueDescription":"Nasopharyngeal Cancer pN1 TNM Finding v7","ValueMeaning":{"publicId":"3914902","version":"1","preferredName":"Nasopharyngeal Cancer pN1 TNM Finding v7","longName":"3914902","preferredDefinition":"Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension.  Midline nodes are considered ipsilateral nodes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN1 TNM Finding v7","conceptCode":"C88972","definition":"Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension.  Midline nodes are considered ipsilateral nodes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0B5D-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0B79-9A6E-E040-BB89AD43310E","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"N2","valueDescription":"Nasopharyngeal Cancer pN2 TNM Finding v7","ValueMeaning":{"publicId":"3914904","version":"1","preferredName":"Nasopharyngeal Cancer pN2 TNM Finding v7","longName":"3914904","preferredDefinition":"Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa.  Midline nodes are considered ipsilateral nodes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN2 TNM Finding v7","conceptCode":"C88973","definition":"Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa.  Midline nodes are considered ipsilateral nodes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0B86-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0BA2-9A6E-E040-BB89AD43310E","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"N3","valueDescription":"Nasopharyngeal Cancer pN3 TNM Finding v7","ValueMeaning":{"publicId":"3914906","version":"1","preferredName":"Nasopharyngeal Cancer pN3 TNM Finding v7","longName":"3914906","preferredDefinition":"Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa.  Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho.  It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder.  This would include caudal portions of levels IV and VB.  All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pN3 TNM Finding v7","conceptCode":"C88974","definition":"Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa.  Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho.  It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder.  This would include caudal portions of levels IV and VB.  All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0BAF-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0BCB-9A6E-E040-BB89AD43310E","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"},{"value":"NX","valueDescription":"Nasopharyngeal Cancer pNX TNM Finding","ValueMeaning":{"publicId":"3914908","version":"1","preferredName":"Nasopharyngeal Cancer pNX TNM Finding","longName":"3914908","preferredDefinition":"Nasopharyngeal cancer in which the regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer pNX TNM Finding v6 and v7","conceptCode":"C64473","definition":"Nasopharyngeal cancer in which the regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0BD8-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7EC41C3-0BF4-9A6E-E040-BB89AD43310E","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3914893","version":"1","preferredName":"Nasopharyngeal Cancer TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A finding about one or more characteristics of nasopharyngeal cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88964:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Cancer TNM Finding v7","conceptCode":"C88964","definition":"A finding about one or more characteristics of nasopharyngeal cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0AB6-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"ONEDATA","dateModified":"2013-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EC41C3-0AC7-9A6E-E040-BB89AD43310E","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"COOPERM","dateModified":"2013-10-09","changeDescription":"Created by RTOG request for CRF standard harmonization. mc 10/4/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3914688","version":"1","longName":"Nasopharyngeal","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000587","version":"1","longName":"Nasopharyngeal","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NASOPHAR_AJCC_PATH_N_STG","type":"OID, RTOG","context":"NCIP"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"E828E37E-D673-7BDB-E040-BB89AD437653","latestVersionIndicator":"Yes","beginDate":"2013-10-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-07","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created per request by RTOG for CRF Harmonization. mc 10/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}